Precision Oncology in Gastro-Esophageal Adenocarcinoma
Gastro-esophageal adenocarcinomas (GEA) are a leading cause of cancer mortality, with limited therapeutic strategies available. With the advent of next-generation sequencing (NGS) and novel technologies, our understanding of its pathogenesis and molecular characterization continues to be improved, a...
Saved in:
| Main Authors: | Marco Cefalì, Celeste Palmarocchi, Sara De Dosso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2020-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2020.05.018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evolving Systemic Treatment for Advanced Hepatocellular Carcinoma
by: Sara De Dosso, et al.
Published: (2021-12-01) -
Multidisciplinary Approach to a Patient with Acinar Cell Carcinoma, a Rare Pancreatic Malignancy
by: Maria Celeste Palmarocchi, et al.
Published: (2021-03-01) -
Benefits and Complications Following First-Line Treatment with Atezolizumab plus Bevacizumab in a Patient with HCC: a Case Report
by: Maria Celeste Palmarocchi, et al.
Published: (2022-03-01) -
Immunotherapy and Tumor Heterogeneity in Advanced Goblet Cell Adenocarcinoma of the Appendix: A Case Report
by: Jana Pankovics, et al.
Published: (2024-12-01) -
Long-term outcome after perioperative chemotherapy and surgery for gastro-esophageal adenocarcinoma
by: S. Shim, et al.
Published: (2025-06-01)